0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and India Radiopharmaceuticals Market Report & Forecast 2023-2029
Published Date: November 2023
|
Report Code: QYRE-Auto-39T15731
Home | Market Reports | Health| Pharmacy
Global and India Radiopharmaceuticals Market Report Forecast 2023 2029
BUY CHAPTERS

Global and India Radiopharmaceuticals Market Report & Forecast 2023-2029

Code: QYRE-Auto-39T15731
Report
November 2023
Pages:112
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

and India Radiopharmaceuticals Market Size

The global Radiopharmaceuticals revenue was US$ 6761 million in 2022 and is forecast to a readjusted size of US$ 11660 million by 2029 with a CAGR of 8.0% during the forecast period (2023-2029).

and India Radiopharmaceuticals Market

and India Radiopharmaceuticals Market

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
In India, the Radiopharmaceuticals revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period (2023-2029).
The major players in global Radiopharmaceuticals market include Bracco Imaging, Bayer, Mallinckrodt, etc. The top 3 players hold over 40% of global market shares. North America and Europe are main markets, they occupy over 70% of the global market. Diagnostic Radioisotopes is the main type, with a share about 90%. Oncology is the key application, which hold over 60% shares.
This report focuses on global and India Radiopharmaceuticals market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Radiopharmaceuticals will continue to grow rapidly in the future.
Global Radiopharmaceuticals Scope and Market Size
Radiopharmaceuticals market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Radiopharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2029.
For India market, this report focuses on the Radiopharmaceuticals market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

Scope of and India Radiopharmaceuticals Market Report

Report Metric Details
Report Name and India Radiopharmaceuticals Market
Forecasted market size in 2029 US$ 11660 million
CAGR 8.0%
Forecasted years 2023 - 2029
Segment by Type
Segment by Application
  • Oncology
  • Cardiology
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bracco Imaging, Bayer, Mallinckrodt, Nordion, Triad Isotopes, Lantheus, IBA Group, GE Healthcare, China Isotope & Radiation, Jubilant Pharma, Eli Lilly, Advanced Accelerator Applications, SIEMENS, Dongcheng, Navidea
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

What is the and India Radiopharmaceuticals Market size in 2029?

Ans: The and India Radiopharmaceuticals Market size in 2029 will be US$ 11660 million.

What is the market share of major companies in and India Radiopharmaceuticals Market?

Ans: The top 3 players hold over 40% of global market shares.

What is the and India Radiopharmaceuticals Market share by region?

Ans: North America and Europe are main markets, they occupy over 70% of the global market. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment.

What is the and India Radiopharmaceuticals Market share by type?

Ans: Diagnostic Radioisotopes is the main type, with a share about 90%.

What is the and India Radiopharmaceuticals Market share by application?

Ans: Oncology is the key application, which hold over 60% shares.

Who are the main players in the and India Radiopharmaceuticals Market report?

Ans: The main players in the and India Radiopharmaceuticals Market are Bracco Imaging, Bayer, Mallinckrodt, Nordion, Triad Isotopes, Lantheus, IBA Group, GE Healthcare, China Isotope & Radiation, Jubilant Pharma, Eli Lilly, Advanced Accelerator Applications, SIEMENS, Dongcheng, Navidea

What are the Application segmentation covered in the and India Radiopharmaceuticals Market report?

Ans: The Applications covered in the and India Radiopharmaceuticals Market report are Oncology, Cardiology, Other

What are the Type segmentation covered in the and India Radiopharmaceuticals Market report?

Ans: The Types covered in the and India Radiopharmaceuticals Market report are Diagnostic Radioisotopes, Therapeutic Radioisotopes

Recommended Reports

Radiopharmaceutical Markets

Radioisotope Applications

Nuclear Medicine Devices

1 Study Coverage
1.1 Radiopharmaceuticals Product Introduction
1.2 Global Radiopharmaceuticals Outlook 2018 VS 2022 VS 2029
1.2.1 Global Radiopharmaceuticals Sales in US$ Million for the Year 2018-2029
1.2.2 Global Radiopharmaceuticals Sales in Volume for the Year 2018-2029
1.3 India Radiopharmaceuticals Outlook 2018 VS 2022 VS 2029
1.3.1 India Radiopharmaceuticals Sales in US$ Million for the Year 2018-2029
1.3.2 India Radiopharmaceuticals Sales in Volume for the Year 2018-2029
1.4 Radiopharmaceuticals Market Size, India VS Global, 2018 VS 2022 VS 2029
1.4.1 The Market Share of India Radiopharmaceuticals in Global, 2018 VS 2022 VS 2029
1.4.2 The Growth Rate of Radiopharmaceuticals Market Size, India VS Global, 2018 VS 2022 VS 2029
1.5 Radiopharmaceuticals Market Dynamics
1.5.1 Radiopharmaceuticals Industry Trends
1.5.2 Radiopharmaceuticals Market Drivers
1.5.3 Radiopharmaceuticals Market Challenges
1.5.4 Radiopharmaceuticals Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 Radiopharmaceuticals by Type
2.1 Radiopharmaceuticals Market Segment by Type
2.1.1 Diagnostic Radioisotopes
2.1.2 Therapeutic Radioisotopes
2.2 Global Radiopharmaceuticals Market Size by Type
2.2.1 Global Radiopharmaceuticals Sales in Value, by Type (2018, 2022 & 2029)
2.2.2 Global Radiopharmaceuticals Sales in Volume, by Type (2018, 2022 & 2029)
2.2.3 Global Radiopharmaceuticals Average Selling Price (ASP) by Type (2018, 2022 & 2029)
2.3 India Radiopharmaceuticals Market Size by Type
2.3.1 India Radiopharmaceuticals Sales in Value, by Type (2018, 2022 & 2029)
2.3.2 India Radiopharmaceuticals Sales in Volume, by Type (2018, 2022 & 2029)
2.3.3 India Radiopharmaceuticals Average Selling Price (ASP) by Type (2018, 2022 & 2029)
3 Radiopharmaceuticals by Application
3.1 Radiopharmaceuticals Market Segment by Application
3.1.1 Oncology
3.1.2 Cardiology
3.1.3 Other
3.2 Global Radiopharmaceuticals Market Size by Application
3.2.1 Global Radiopharmaceuticals Sales in Value, by Application (2018, 2022 & 2029)
3.2.2 Global Radiopharmaceuticals Sales in Volume, by Application (2018, 2022 & 2029)
3.3.3 Global Radiopharmaceuticals Average Selling Price (ASP) by Application (2018, 2022 & 2029)
3.3 India Radiopharmaceuticals Market Size by Application
3.3.1 India Radiopharmaceuticals Sales in Value, by Application (2018, 2022 & 2029)
3.3.2 India Radiopharmaceuticals Sales in Volume, by Application (2018, 2022 & 2029)
3.3.3 India Radiopharmaceuticals Average Selling Price (ASP) by Application (2018, 2022 & 2029)
4 Global Radiopharmaceuticals Competitor Landscape by Company
4.1 Global Radiopharmaceuticals Market Size by Company
4.1.1 Global Key Manufacturers of Radiopharmaceuticals, Ranked by Revenue (2022)
4.1.2 Global Radiopharmaceuticals Revenue by Manufacturer (2018-2023)
4.1.3 Global Radiopharmaceuticals Sales by Manufacturer (2018-2023)
4.1.4 Global Radiopharmaceuticals Price by Manufacturer (2018-2023)
4.2 Global Radiopharmaceuticals Concentration Ratio (CR)
4.2.1 Radiopharmaceuticals Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Radiopharmaceuticals in 2022
4.2.3 Global Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Radiopharmaceuticals, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Radiopharmaceuticals, Product Offered and Application
4.5 Global Key Manufacturers of Radiopharmaceuticals, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 India Radiopharmaceuticals Market Size by Company
4.7.1 Key Players of Radiopharmaceuticals in India, Ranked by Revenue (2022)
4.7.2 India Radiopharmaceuticals Revenue by Players (2018-2023)
4.7.3 India Radiopharmaceuticals Sales by Players (2018-2023)
5 Global Radiopharmaceuticals Market Size by Region
5.1 Global Radiopharmaceuticals Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Radiopharmaceuticals Market Size in Volume by Region (2018-2029)
5.2.1 Global Radiopharmaceuticals Sales in Volume by Region: 2018-2023
5.2.2 Global Radiopharmaceuticals Sales in Volume Forecast by Region (2024-2029)
5.3 Global Radiopharmaceuticals Market Size in Value by Region (2018-2029)
5.3.1 Global Radiopharmaceuticals Sales in Value by Region: 2018-2023
5.3.2 Global Radiopharmaceuticals Sales in Value by Region: 2024-2029
6 Americas
6.1 Americas Radiopharmaceuticals Market Size YoY Growth 2018-2029
6.2 Americas Radiopharmaceuticals Sales in Volume, by Type (2018, 2022 & 2029)
6.3 Americas Radiopharmaceuticals Sales in Volume, by Application (2018, 2022 & 2029)
6.4 Americas Radiopharmaceuticals Market Facts & Figures by Country (2018, 2022 & 2029)
6.4.1 Americas Radiopharmaceuticals Sales in Value by Country (2018, 2022 & 2029)
6.4.2 Americas Radiopharmaceuticals Sales in Volume by Country (2018, 2022 & 2029)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Radiopharmaceuticals Market Size YoY Growth 2018-2029
7.2 EMEA Radiopharmaceuticals Sales in Volume, by Type (2018, 2022 & 2029)
7.3 EMEA Radiopharmaceuticals Sales in Volume, by Application (2018, 2022 & 2029)
7.4 EMEA Radiopharmaceuticals Market Facts & Figures by Country (2018, 2022 & 2029)
7.4.1 EMEA Radiopharmaceuticals Sales in Value by Country (2018, 2022 & 2029)
7.4.2 EMEA Radiopharmaceuticals Sales in Volume by Country (2018, 2022 & 2029)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Radiopharmaceuticals Market Size YoY Growth 2018-2029
8.2 China Radiopharmaceuticals Sales in Volume, by Type (2018, 2022 & 2029)
8.3 China Radiopharmaceuticals Sales in Volume, by Application (2018, 2022 & 2029)
9 APAC
9.1 APAC Radiopharmaceuticals Market Size YoY Growth 2018-2029
9.2 APAC Radiopharmaceuticals Sales in Volume, by Type (2018, 2022 & 2029)
9.3 APAC Radiopharmaceuticals Sales in Volume, by Application (2018, 2022 & 2029)
9.4 APAC Radiopharmaceuticals Market Facts & Figures by Region (2018, 2022 & 2029)
9.4.1 APAC Radiopharmaceuticals Sales in Value by Region (2018, 2022 & 2029)
9.4.2 APAC Radiopharmaceuticals Sales in Volume by Region (2018, 2022 & 2029)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Bracco Imaging
10.1.1 Bracco Imaging Company Information
10.1.2 Bracco Imaging Description and Business Overview
10.1.3 Bracco Imaging Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Bracco Imaging Radiopharmaceuticals Products Offered
10.1.5 Bracco Imaging Recent Development
10.2 Bayer
10.2.1 Bayer Company Information
10.2.2 Bayer Description and Business Overview
10.2.3 Bayer Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Bayer Radiopharmaceuticals Products Offered
10.2.5 Bayer Recent Development
10.3 Mallinckrodt
10.3.1 Mallinckrodt Company Information
10.3.2 Mallinckrodt Description and Business Overview
10.3.3 Mallinckrodt Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Mallinckrodt Radiopharmaceuticals Products Offered
10.3.5 Mallinckrodt Recent Development
10.4 Nordion
10.4.1 Nordion Company Information
10.4.2 Nordion Description and Business Overview
10.4.3 Nordion Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Nordion Radiopharmaceuticals Products Offered
10.4.5 Nordion Recent Development
10.5 Triad Isotopes
10.5.1 Triad Isotopes Company Information
10.5.2 Triad Isotopes Description and Business Overview
10.5.3 Triad Isotopes Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Triad Isotopes Radiopharmaceuticals Products Offered
10.5.5 Triad Isotopes Recent Development
10.6 Lantheus
10.6.1 Lantheus Company Information
10.6.2 Lantheus Description and Business Overview
10.6.3 Lantheus Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Lantheus Radiopharmaceuticals Products Offered
10.6.5 Lantheus Recent Development
10.7 IBA Group
10.7.1 IBA Group Company Information
10.7.2 IBA Group Description and Business Overview
10.7.3 IBA Group Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
10.7.4 IBA Group Radiopharmaceuticals Products Offered
10.7.5 IBA Group Recent Development
10.8 GE Healthcare
10.8.1 GE Healthcare Company Information
10.8.2 GE Healthcare Description and Business Overview
10.8.3 GE Healthcare Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
10.8.4 GE Healthcare Radiopharmaceuticals Products Offered
10.8.5 GE Healthcare Recent Development
10.9 China Isotope & Radiation
10.9.1 China Isotope & Radiation Company Information
10.9.2 China Isotope & Radiation Description and Business Overview
10.9.3 China Isotope & Radiation Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
10.9.4 China Isotope & Radiation Radiopharmaceuticals Products Offered
10.9.5 China Isotope & Radiation Recent Development
10.10 Jubilant Pharma
10.10.1 Jubilant Pharma Company Information
10.10.2 Jubilant Pharma Description and Business Overview
10.10.3 Jubilant Pharma Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Jubilant Pharma Radiopharmaceuticals Products Offered
10.10.5 Jubilant Pharma Recent Development
10.11 Eli Lilly
10.11.1 Eli Lilly Company Information
10.11.2 Eli Lilly Description and Business Overview
10.11.3 Eli Lilly Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Eli Lilly Radiopharmaceuticals Products Offered
10.11.5 Eli Lilly Recent Development
10.12 Advanced Accelerator Applications
10.12.1 Advanced Accelerator Applications Company Information
10.12.2 Advanced Accelerator Applications Description and Business Overview
10.12.3 Advanced Accelerator Applications Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Advanced Accelerator Applications Radiopharmaceuticals Products Offered
10.12.5 Advanced Accelerator Applications Recent Development
10.13 SIEMENS
10.13.1 SIEMENS Company Information
10.13.2 SIEMENS Description and Business Overview
10.13.3 SIEMENS Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
10.13.4 SIEMENS Radiopharmaceuticals Products Offered
10.13.5 SIEMENS Recent Development
10.14 Dongcheng
10.14.1 Dongcheng Company Information
10.14.2 Dongcheng Description and Business Overview
10.14.3 Dongcheng Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Dongcheng Radiopharmaceuticals Products Offered
10.14.5 Dongcheng Recent Development
10.15 Navidea
10.15.1 Navidea Company Information
10.15.2 Navidea Description and Business Overview
10.15.3 Navidea Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Navidea Radiopharmaceuticals Products Offered
10.15.5 Navidea Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Radiopharmaceuticals Industry Chain Analysis
11.2 Radiopharmaceuticals Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Radiopharmaceuticals Production Mode & Process
11.4 Radiopharmaceuticals Sales and Marketing
11.4.1 Radiopharmaceuticals Sales Channels
11.4.2 Radiopharmaceuticals Distributors
11.5 Radiopharmaceuticals Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
    Table 1. Radiopharmaceuticals CAGR in Value, India VS Global, 2018 VS 2022 VS 2029
    Table 2. Radiopharmaceuticals Market Trends
    Table 3. Radiopharmaceuticals Market Drivers
    Table 4. Radiopharmaceuticals Market Challenges
    Table 5. Radiopharmaceuticals Market Restraints
    Table 6. Global Radiopharmaceuticals Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 7. India Radiopharmaceuticals Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 8. Global Radiopharmaceuticals Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 9. India Radiopharmaceuticals Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 10. Global Key Manufacturers of Radiopharmaceuticals, Ranked by Revenue (2022) & (US$ Million)
    Table 11. Global Radiopharmaceuticals Revenue by Manufacturer, (US$ Million), 2018-2023
    Table 12. Global Radiopharmaceuticals Revenue Share by Manufacturer, 2018-2023
    Table 13. Global Radiopharmaceuticals Sales by Manufacturer, (K Units), 2018-2023
    Table 14. Global Radiopharmaceuticals Sales Share by Manufacturer, 2018-2023
    Table 15. Global Radiopharmaceuticals Price by Manufacturer (2018-2023) & (USD/Unit)
    Table 16. Global Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Radiopharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceuticals as of 2022)
    Table 18. Global Key Manufacturers of Radiopharmaceuticals, Manufacturing Base Distribution and Headquarters
    Table 19. Global Key Manufacturers of Radiopharmaceuticals, Product Offered and Application
    Table 20. Global Key Manufacturers of Radiopharmaceuticals, Date of Enter into This Industry
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Key Players of Radiopharmaceuticals in India, Ranked by Revenue (2022) & (US$ million)
    Table 23. India Radiopharmaceuticals Revenue by Players, (US$ Million), (2018-2023)
    Table 24. India Radiopharmaceuticals Revenue Share by Players, (2018-2023)
    Table 25. India Radiopharmaceuticals Sales by Players, (K Units), (2018-2023)
    Table 26. India Radiopharmaceuticals Sales Share by Players, (2018-2023)
    Table 27. Global Radiopharmaceuticals Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 28. Global Radiopharmaceuticals Sales in Volume by Region (2018-2023) & (K Units)
    Table 29. Global Radiopharmaceuticals Sales in Volume Forecast by Region (2024-2029) & (K Units)
    Table 30. Global Radiopharmaceuticals Sales in Value by Region (2018-2023) & (US$ Million)
    Table 31. Global Radiopharmaceuticals Sales in Value Forecast by Region (2024-2029) & (US$ Million)
    Table 32. Americas Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 33. Americas Radiopharmaceuticals Sales in Value by Country (2018-2023) & (US$ Million)
    Table 34. Americas Radiopharmaceuticals Sales in Value by Country (2024-2029) & (US$ Million)
    Table 35. Americas Radiopharmaceuticals Sales in Volume by Country (2018-2023) & (K Units)
    Table 36. Americas Radiopharmaceuticals Sales in Volume by Country (2024-2029) & (K Units)
    Table 37. EMEA Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 38. EMEA Radiopharmaceuticals Sales in Value by Country (2018-2023) & (US$ Million)
    Table 39. EMEA Radiopharmaceuticals Sales in Value by Country (2024-2029) & (US$ Million)
    Table 40. EMEA Radiopharmaceuticals Sales in Volume by Country (2018-2023) & (K Units)
    Table 41. EMEA Radiopharmaceuticals Sales in Volume by Country (2024-2029) & (K Units)
    Table 42. APAC Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 43. APAC Radiopharmaceuticals Sales in Value by Country (2018-2023) & (US$ Million)
    Table 44. APAC Radiopharmaceuticals Sales in Value by Country (2024-2029) & (US$ Million)
    Table 45. APAC Radiopharmaceuticals Sales in Volume by Country (2018-2023) & (K Units)
    Table 46. APAC Radiopharmaceuticals Sales in Volume by Country (2024-2029) & (K Units)
    Table 47. Bracco Imaging Company Information
    Table 48. Bracco Imaging Description and Business Overview
    Table 49. Bracco Imaging Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 50. Bracco Imaging Radiopharmaceuticals Product
    Table 51. Bracco Imaging Recent Development
    Table 52. Bayer Company Information
    Table 53. Bayer Description and Business Overview
    Table 54. Bayer Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 55. Bayer Radiopharmaceuticals Product
    Table 56. Bayer Recent Development
    Table 57. Mallinckrodt Company Information
    Table 58. Mallinckrodt Description and Business Overview
    Table 59. Mallinckrodt Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 60. Mallinckrodt Radiopharmaceuticals Product
    Table 61. Mallinckrodt Recent Development
    Table 62. Nordion Company Information
    Table 63. Nordion Description and Business Overview
    Table 64. Nordion Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 65. Nordion Radiopharmaceuticals Product
    Table 66. Nordion Recent Development
    Table 67. Triad Isotopes Company Information
    Table 68. Triad Isotopes Description and Business Overview
    Table 69. Triad Isotopes Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 70. Triad Isotopes Radiopharmaceuticals Product
    Table 71. Triad Isotopes Recent Development
    Table 72. Lantheus Company Information
    Table 73. Lantheus Description and Business Overview
    Table 74. Lantheus Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 75. Lantheus Radiopharmaceuticals Product
    Table 76. Lantheus Recent Development
    Table 77. IBA Group Company Information
    Table 78. IBA Group Description and Business Overview
    Table 79. IBA Group Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 80. IBA Group Radiopharmaceuticals Product
    Table 81. IBA Group Recent Development
    Table 82. GE Healthcare Company Information
    Table 83. GE Healthcare Description and Business Overview
    Table 84. GE Healthcare Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 85. GE Healthcare Radiopharmaceuticals Product
    Table 86. GE Healthcare Recent Development
    Table 87. China Isotope & Radiation Company Information
    Table 88. China Isotope & Radiation Description and Business Overview
    Table 89. China Isotope & Radiation Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 90. China Isotope & Radiation Radiopharmaceuticals Product
    Table 91. China Isotope & Radiation Recent Development
    Table 92. Jubilant Pharma Company Information
    Table 93. Jubilant Pharma Description and Business Overview
    Table 94. Jubilant Pharma Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 95. Jubilant Pharma Radiopharmaceuticals Product
    Table 96. Jubilant Pharma Recent Development
    Table 97. Eli Lilly Company Information
    Table 98. Eli Lilly Description and Business Overview
    Table 99. Eli Lilly Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 100. Eli Lilly Radiopharmaceuticals Product
    Table 101. Eli Lilly Recent Development
    Table 102. Advanced Accelerator Applications Company Information
    Table 103. Advanced Accelerator Applications Description and Business Overview
    Table 104. Advanced Accelerator Applications Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 105. Advanced Accelerator Applications Radiopharmaceuticals Product
    Table 106. Advanced Accelerator Applications Recent Development
    Table 107. SIEMENS Company Information
    Table 108. SIEMENS Description and Business Overview
    Table 109. SIEMENS Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 110. SIEMENS Radiopharmaceuticals Product
    Table 111. SIEMENS Recent Development
    Table 112. Dongcheng Company Information
    Table 113. Dongcheng Description and Business Overview
    Table 114. Dongcheng Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 115. Dongcheng Radiopharmaceuticals Product
    Table 116. Dongcheng Recent Development
    Table 117. Navidea Company Information
    Table 118. Navidea Description and Business Overview
    Table 119. Navidea Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 120. Navidea Radiopharmaceuticals Product
    Table 121. Navidea Recent Development
    Table 122. Key Raw Materials Lists
    Table 123. Raw Materials Key Suppliers Lists
    Table 124. Radiopharmaceuticals Customers List
    Table 125. Radiopharmaceuticals Distributors List
    Table 126. Research Programs/Design for This Report
    Table 127. Key Data Information from Secondary Sources
    Table 128. Key Data Information from Primary Sources
List of Figures
    Figure 1. Radiopharmaceuticals Product Picture
    Figure 2. Global Radiopharmaceuticals Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Radiopharmaceuticals Market Size 2018-2029 (US$ Million)
    Figure 4. Global Radiopharmaceuticals Sales 2018-2029 (K Units)
    Figure 5. India Radiopharmaceuticals Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 6. India Radiopharmaceuticals Market Size 2018-2029 (US$ Million)
    Figure 7. India Radiopharmaceuticals Sales 2018-2029 (K Units)
    Figure 8. India Radiopharmaceuticals Market Share in Global, in Value (US$ Million) 2018-2029
    Figure 9. India Radiopharmaceuticals Market Share in Global, in Volume (K Units) 2018-2029
    Figure 10. Radiopharmaceuticals Report Years Considered
    Figure 11. Product Picture of Diagnostic Radioisotopes
    Figure 12. Product Picture of Therapeutic Radioisotopes
    Figure 13. Global Radiopharmaceuticals Market Share by Type in 2022 & 2029
    Figure 14. Global Radiopharmaceuticals Sales in Value by Type (2018-2029) & (US$ Million)
    Figure 15. Global Radiopharmaceuticals Sales Market Share in Value by Type (2018-2029)
    Figure 16. Global Radiopharmaceuticals Sales by Type (2018-2029) & (K Units)
    Figure 17. Global Radiopharmaceuticals Sales Market Share in Volume by Type (2018-2029)
    Figure 18. Global Radiopharmaceuticals Price by Type (2018-2029) & (USD/Unit)
    Figure 19. India Radiopharmaceuticals Market Share by Type in 2022 & 2029
    Figure 20. India Radiopharmaceuticals Sales in Value by Type (2018-2029) & (US$ Million)
    Figure 21. India Radiopharmaceuticals Sales Market Share in Value by Type (2018-2029)
    Figure 22. India Radiopharmaceuticals Sales by Type (2018-2029) & (K Units)
    Figure 23. India Radiopharmaceuticals Sales Market Share in Volume by Type (2018-2029)
    Figure 24. India Radiopharmaceuticals Price by Type (2018-2029) & (USD/Unit)
    Figure 25. Product Picture of Oncology
    Figure 26. Product Picture of Cardiology
    Figure 27. Product Picture of Other
    Figure 28. Global Radiopharmaceuticals Market Share by Application in 2022 & 2029
    Figure 29. Global Radiopharmaceuticals Sales in Value by Application (2018-2029) & (US$ Million)
    Figure 30. Global Radiopharmaceuticals Sales Market Share in Value by Application (2018-2029)
    Figure 31. Global Radiopharmaceuticals Sales by Application (2018-2029) & (K Units)
    Figure 32. Global Radiopharmaceuticals Sales Market Share in Volume by Application (2018-2029)
    Figure 33. Global Radiopharmaceuticals Price by Application (2018-2029) & (USD/Unit)
    Figure 34. India Radiopharmaceuticals Market Share by Application in 2022 & 2029
    Figure 35. India Radiopharmaceuticals Sales in Value by Application (2018-2029) & (US$ Million)
    Figure 36. India Radiopharmaceuticals Sales Market Share in Value by Application (2018-2029)
    Figure 37. India Radiopharmaceuticals Sales by Application (2018-2029) & (K Units)
    Figure 38. India Radiopharmaceuticals Sales Market Share in Volume by Application (2018-2029)
    Figure 39. India Radiopharmaceuticals Price by Application (2018-2029) & (USD/Unit)
    Figure 40. Americas Radiopharmaceuticals Sales in Volume Growth Rate 2018-2029 (K Units)
    Figure 41. Americas Radiopharmaceuticals Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 42. Americas Radiopharmaceuticals Sales by Type (2018-2029) & (K Units)
    Figure 43. Americas Radiopharmaceuticals Sales Market Share in Volume by Type (2018-2029)
    Figure 44. Americas Radiopharmaceuticals Sales by Application (2018-2029) & (K Units)
    Figure 45. Americas Radiopharmaceuticals Sales Market Share in Volume by Application (2018-2029)
    Figure 46. United States Radiopharmaceuticals Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 47. Canada Radiopharmaceuticals Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 48. Mexico Radiopharmaceuticals Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 49. Brazil Radiopharmaceuticals Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 50. EMEA Radiopharmaceuticals Sales in Volume Growth Rate 2018-2029 (K Units)
    Figure 51. EMEA Radiopharmaceuticals Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 52. EMEA Radiopharmaceuticals Sales by Type (2018-2029) & (K Units)
    Figure 53. EMEA Radiopharmaceuticals Sales Market Share in Volume by Type (2018-2029)
    Figure 54. EMEA Radiopharmaceuticals Sales by Application (2018-2029) & (K Units)
    Figure 55. EMEA Radiopharmaceuticals Sales Market Share in Volume by Application (2018-2029)
    Figure 56. Europe Radiopharmaceuticals Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 57. Middle East Radiopharmaceuticals Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 58. Africa Radiopharmaceuticals Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 59. China Radiopharmaceuticals Sales in Volume Growth Rate 2018-2029 (K Units)
    Figure 60. China Radiopharmaceuticals Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 61. China Radiopharmaceuticals Sales by Type (2018-2029) & (K Units)
    Figure 62. China Radiopharmaceuticals Sales Market Share in Volume by Type (2018-2029)
    Figure 63. China Radiopharmaceuticals Sales by Application (2018-2029) & (K Units)
    Figure 64. China Radiopharmaceuticals Sales Market Share in Volume by Application (2018-2029)
    Figure 65. APAC Radiopharmaceuticals Sales in Volume Growth Rate 2018-2029 (K Units)
    Figure 66. APAC Radiopharmaceuticals Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 67. APAC Radiopharmaceuticals Sales by Type (2018-2029) & (K Units)
    Figure 68. APAC Radiopharmaceuticals Sales Market Share in Volume by Type (2018-2029)
    Figure 69. APAC Radiopharmaceuticals Sales by Application (2018-2029) & (K Units)
    Figure 70. APAC Radiopharmaceuticals Sales Market Share in Volume by Application (2018-2029)
    Figure 71. Japan Radiopharmaceuticals Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 72. South Korea Radiopharmaceuticals Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 73. China Taiwan Radiopharmaceuticals Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 74. Southeast Asia Radiopharmaceuticals Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 75. India Radiopharmaceuticals Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 76. Radiopharmaceuticals Value Chain
    Figure 77. Radiopharmaceuticals Production Process
    Figure 78. Channels of Distribution
    Figure 79. Distributors Profiles
    Figure 80. Bottom-up and Top-down Approaches for This Report
    Figure 81. Data Triangulation
    Figure 82. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4350

This license allows only one user to access the PDF.
Electronic (PDF)

$6525

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$8700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Levothyroxine Sodium Tablets Hormone Medication Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-25N19924
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Needle Free Allergy Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24B19783
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Hydrotalcite Antacid Chewable Tablets Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20305
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Dual Orexin Receptor Antagonist Sleeping Pills Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12S20176
Mon Nov 24 00:00:00 UTC 2025

Add to Cart